Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
4 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
3 - Nautilus Biotechnology, Inc. (0001808805) (Issuer)
D - Nautilus Biotechnology, Inc. (0001808805) (Filer)
8-K - Nautilus Biotechnology, Inc. (0001808805) (Filer)
425 - ARYA Sciences Acquisition Corp III (0001808805) (Subject)
SIOUX FALLS, S.D., July 8, 2021 /PRNewswire-PRWeb/ -- MarketBeat, a leading source for stock market data and research tools, has published a monthly list ranking The 10 Stocks with the Most Insider Buying in June 2021. An insider trade occurs when a company executive or individual who has non-public information about a company buys or sells shares of that company's stock. The level of stock that insiders are buying is a potential indicator of the stock's future performance. The MarketBeat editorial team compiled the 10 stocks with the most insider trading by utilizing the company's Stocks with the Most Insider Buying Report. For stocks with the most insider buying, software companies and s
Business combination transaction with Arya Sciences Acquisition Corp III, a special purpose acquisition company sponsored by Perceptive Advisors, closed on June 9, 2021Publicly traded company renamed Nautilus Biotechnology, Inc.Common stock commences trading under ticker symbol “NAUT” on the Nasdaq Global Select Market on June 10, 2021Gross proceeds from this transaction to Nautilus totaled approximately $345 million, combining approximately $145 million of funds held in Arya III’s trust account and a concurrent PIPE financing of $200 million SEATTLE and NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis pla
NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- ARYA Sciences Acquisition Corp III ("ARYA") (NASDAQ:ARYA), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, ARYA is strongly encouraging that shareholders attend the extraordinary general meeting of its shareholders on June 8, 2021 at 9:00 a.m., New York City Time (the "General Meeting") remotely by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced Business Combination Agreement, dated as of February 7, 2021 (the "Business
SC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)
SC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)
SC 13D - Nautilus Biotechnology, Inc. (0001808805) (Subject)